APOE and intracerebral hemorrhage: Another APOE mimetic peptide derived from the receptor binding region of APOE α helix, CN-105 (Ac-V-S-R-R-R-NH2) has successfully completed Phase I clinical trial in patients with intracerebral hemorrhage (ICH) (Table 1).